Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies
Open Access
- 29 August 2022
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 22, 100492
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim France SAS
- Fondation du Souffle
- Institut National Du Cancer
- AstraZeneca France
This publication has 26 references indexed in Scilit:
- Sex steroid signaling: Implications for lung diseasesPharmacology & Therapeutics, 2015
- No impact of passive smoke on the somatic profile of lung cancers in never-smokersEuropean Respiratory Journal, 2015
- BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokersEuropean Respiratory Journal, 2015
- Screening for Cognitive Impairment in Older Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2014
- Estrogenic Steroid Hormones in Lung CancerSeminars in Oncology, 2014
- Major changes in lung cancer over the last ten years in France: The KBP-CPHG studiesLung Cancer, 2013
- Lung cancer in never smokers – A reviewEuropean Journal of Cancer, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung CancerChest, 2011
- Étude KBP-2010-CPHG : recueil des nouveaux cas de cancer bronchopulmonaire primitif diagnostiqués dans les services de pneumologie des centres hospitaliers généraux du 1er janvier au 31 décembre 2010Revue de Pneumologie Clinique, 2010